Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Vital Products, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R8.htm
EX-32 - EXHIBIT 32 - Vital Products, Inc.exhibit32.htm
EX-31 - EXHIBIT 31 - Vital Products, Inc.exhibit31.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Vital Products, Inc.R22.htm



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended: October 31, 2012


OR


¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from __________ to __________


Commission File No. 333-127915


VITAL PRODUCTS, INC.

(Exact name of registrant as specified in its charter)


Delaware

  

98-0464272

(State or other jurisdiction of incorporation)

  

(IRS Employer Identification No.)


2404 Via Mariposa West, 1-A, Laguna Woods, California 92637

 (Address of principal executive offices)


(949) 306-3110

(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.  
Yes o  No o


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer

o

  

Accelerated filer

o

  

 

  

  

 

Non-accelerated filer

o

  

Smaller reporting company

x


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  
Yes o  No x


As of December 13, 2012, the Issuer had 579,296,457 shares of common stock issued and outstanding, par value $0.0001 per share.



1






VITAL PRODUCTS, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED OCTOBER 31, 2012


TABLE OF CONTENTS



  

PART I – FINANCIAL INFORMATION

 

 

 

 

Item 1.

Consolidated Financial Statements

F-1

 

 

 

  

 Consolidated Balance Sheets as of October 31, 2012 and July 31, 2012

F-2

 

 

 

 

Consolidated Statements of Operations and Comprehensive Loss for the three months ended October 31, 2012 and 2011

F-3

 

 

 

 

Consolidated Statements of Cash Flows for the three months ended

October 31, 2012 and 2011

F-4

 

 

 

 

Notes to Consolidated Financial Statements

F-5

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

3

  

  

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

6

  

  

 

Item 4.T

Controls and Procedures.

6

 

 

 

  

PART II – OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings.

6

  

  

 

Item 1A.

Risk Factors.

6

  

  

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds.

6

  

  

 

Item 3

Defaults Upon Senior Securities.

6

  

  

 

Item 4.

Mine Safety Disclosures.

7

  

  

 

Item 5.

Other Information.

7

  

  

 

Item 6.

Exhibits.

8

  

  

 

Signatures

9




2




 

PART I - FINANCIAL INFORMATION


ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

 

 

 

 



 

F-1




 

VITAL PRODUCTS, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

October 31,
2012

 

July 31,

 2012

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Cash

 

$

20,072

 

$

1,050

 

Accounts receivable – related party

 

103,554

 

 

128,320

 

Inventory

 

124,060

 

 

115,213

 

 

 

 

 

 

 

 

 

Total current assets                       

 

247,686

 

 

244,583

 

 

 

 

 

 

 

 

Total assets                                         

 

$

247,686

 

$

244,583

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable and accrued liabilities

$

308,966

 

$

324,594

 

Accounts payable and accrued liabilities – related party

 

191,124

 

 

195,001

 

Provision for sales returns

 

7,000

 

 

2,000

 

Advances

 

93,233

 

 

56,040

 

Convertible notes payable, net

 

277,403

 

 

244,403

 

Advances from related parties

 

142,228

 

 

135,930

 

 

 

 

 

 

 

 

 

 

Total current liabilities      

 

1,019,954

 

 

987,968

 

 

 

 

 

 

 

 

Total liabilities                              

 

1,019,954

 

 

987,968

 

 

 

 

 

 

 

 

Stockholders’ deficit

 

 

 

 

 

 

Preferred Stock; $0.01 par value; authorized undesignated 900,000 shares, no shares issued and outstanding

Series A Convertible Preferred Stock; $0.01 par value;100,000 shares authorized, 100,000 and 100,000 issued and outstanding, respectively                                           

 

1,000

 

 

1,000

 

Common stock; $0.0001 par value;

1,000,000,000 shares authorized and

579,296,457 and 579,296,457 issued and outstanding, respectively

 

57,930

 

 

57,930

 

Additional paid-in capital                        

 

3,803,744

 

 

3,803,744

 

Accumulated other comprehensive income

 

47,181

 

 

47,181

 

Accumulated deficit

 

(4,671,692)

 

 

(4,629,191)

 

Total Vital Products, Inc. stockholders’ deficit

 

(761,837)

 

 

(719,336)

 

Noncontrolling interest

 

(10,431)

 

 

(24,049)

 

Total deficit

 

(772,268)

 

 

(743,385)

 

 

 

 

 

 

 

 

Total liabilities and deficit

$

251,686

 

$

244,583


The accompanying notes are an integral part of these consolidated financial statements




F-2






VITAL PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

 

 

 

For the three months ended October 31, 2012

 

For the
three months ended October 31, 2011

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

 

$

554,458 

 

$

4,634 

 

Cost of sales

 

 

 

 

484,618 

 

 

2,754 

 

Gross profit

 

 

 

 

69,840 

 

 

1,880 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 Selling, general and administrative

 

 

 

72,981 

 

 

22,130 

 


Total expenses

 

 

 

 

72,981 

 

 

22,130 

 


Net operating loss

 

 

 

 

(3,141)

 

 

(20,250)

 

 

 

 

 

 

 

 

 

 

 

Other income (loss)

 

 

 

 

 

 

 

 

 

Financing costs

 

 

 

(33,000)

 

 

(35,456)

 

Gain on settlement of debt

 

 

 

 

 

4,800 

 

Gain (loss) on currency exchange rate

 

 

 

7,258 

 

 

(12,180)

 


Net loss

 

 

 

(28,883)

 

 

(63,086)

 


Net loss attributed to noncontrolling interest

 

 

 

(13,618)

 

 

 


Net loss attributable to Vital Products, Inc.

 

 

 

(42,501)

 

 

(63,086)

 


Other comprehensive income (loss)

Foreign currency translation adjustment

 

 

 

 

 

27,958 

 


Comprehensive loss

 

 

 

 

(42,501)

 

 

(35,128)

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Vital Products Inc. per common share, basic

 

 

$

(0.00)

 

$

(0.00)

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding – basic

 

 

 579,296,457

 

 296,456,555 

 


The accompanying notes are an integral part of these consolidated financial statements



 

F-3

 


 

VITAL PRODUCTS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

 

For the three months ended October 31, 2012

 

For the three months ended October 31, 2011

Cash flows from operating activities

 

 

 

 

 

 

 

Net loss                    

 

 

$

(28,883)

 

 

$

(63,086)

 

Adjustments to reconcile net loss

to cash used in operating activities

 

 

 

 

 

 

 

 

Accretion of debt discount and interest expense        

 

 

33,000 

 

 

35,456 

 

 

(Gain) loss on currency exchange                        

 

 

(7,258)

 

 

12,180 

 

 

Gain on settlement of debt

 

 

 

 

(4,800)

 

Change in operating assets and liabilities

 

 

 

 

 

 

 

 

Accounts receivable

 

 

24,766 

 

 

4,110 

 

 

Inventory

 

 

(8,847)

 

 

(3,662)

 

 

Accounts payable and accrued liabilities

 

 

(14,949)

 

 

1,446 

 

 

Provision for sales returns

 

 

5,000 

 

 

 

Net cash provided by (used in) operating activities                                     

 

 

2,829 

 

 

(18,356)

 

 

 

 

 

 

 

 

 


Cash flow from financing activities

 

 

 

 

 

 

 

 

Advances

 

 

11,193 

 

 

40,500 

Payments on advances

(4,000)

 

-

 

 

Advances from related party

 

 

9,000 

 

 

 

 

Payments on related party advances

 

 

 

 

(20,000)

 

Net cash provided by financing  activities         

 

 

16,193 

 

 

20,500 

 

 

 

 

 

 

 

 

 

Foreign currency translation effect

 

 

 

 

(436)

 

 

 

 

 

 

 

 

 

Net change in cash                           

 

 

19,022 

 

 

1,708 

 

 

 

 

 

 

 

Cash, beginning of the period                

 

 

1,050 

 

 

3,869 

 

 

 

 

 

 

 

 

 

Cash, end of the period                

 

 

$

20,072 

 

 

$

5,577 


The accompanying notes are an integral part of these consolidated financial statements


 

F-4



VITAL PRODUCTS, INC.

Notes to Consolidated Financial Statements

October 31, 2012 and 2011

(Unaudited)


NOTE 1 - NATURE OF OPERATIONS AND BASIS FOR PRESENTATION


The accompanying unaudited interim consolidated financial statements of Vital Products, Inc. have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission requirements for interim financial statements. Therefore, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The interim consolidated financial statements should be read in conjunction with the annual consolidated financial statements for the year ended July 31, 2012 of Vital Products, Inc.


The interim consolidated financial statements present the balance sheets, statements of operations and comprehensive loss and cash flows of Vital Products, Inc. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States.


The interim financial information is unaudited. In the opinion of management, all adjustments necessary to present fairly the financial position as of October 31, 2012 and the results of operations and cash flows presented herein have been included in the interim consolidated financial statements. All such adjustments are of a normal and recurring nature.  Interim results are not necessarily indicative of results of operations for the full year.


On April 26, 2012, we entered into a License Agreement with Vital Products Supplies, Inc. (“Vital Supplies”). Under the terms of the Agreement, we have the right to market the products of Vital Supplies as well as the right of use of the facilities of Vital Supplies including but not limited to the sales and distribution facilities. We agreed to pay a fee of 1.5% of all sales generated plus a management fee of 1.5% based on the total monies paid for employee salaries, benefits and commissions. The Company is responsible for all expenses that relate to sales generated under the License Agreement.  The duration of the agreement is for a period of twelve months commencing on April 26, 2012 and thereafter on a month-by-month basis unless sooner terminated by Vital Supplies as provided for in the agreement. Vital Supplies may at any time in its sole discretion, with sixty days prior notice, terminate the agreement and revoke the license granted for any reason whatsoever and upon such termination we will immediately stop the use of the facilities as described.


The Company has determined that Vital Supplies is a Variable Interest Entity and that Vital Products, Inc. is the primary beneficiary. As such, Vital Supplies has been consolidated into the Company’s financial statements.


NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES


Liquidity and Going Concern


During the three months ended October 31, 2012 and 2011, the Company incurred losses of $28,883 and $63,086, respectively, and cash provided by (used in) operations was $2,829 and $(18,356), respectively.  The Company financed its operations through convertible notes payable, advances from related parties and vendors' credit.


Management believes that the current cash balance at October 31, 2012 and net cash proceeds from operations will not be sufficient to meet the Company's cash requirements for the next twelve months.


Accordingly, these financial statements have been prepared on a going concern basis and do not include any adjustments to the measurement and classification of the recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.  The Company has experienced losses in the period and has negative working capital. The Company's ability to realize its assets and discharge its liabilities in the normal course of business is dependent upon continued support. The Company is currently attempting to obtain additional financing from its existing shareholders and other strategic investors to continue its operations. However, the Company may not obtain sufficient additional funds from these sources.



F-5





These conditions cause substantial doubt about the Company's ability to continue as a going concern.  A failure to continue as a going concern would require that stated amounts of assets and liabilities be reflected on a liquidation basis that could differ from the going concern basis. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the company cannot continue in existence.


ACCOUNTING PRINCIPLES


The Company's accounting and reporting policies conform to generally accepted accounting principles in the United States.  The consolidated financial statements are reported in United States dollars.


CONSOLIDATION


The consolidated financial statements include the accounts of the Company and its variable interest entity ("VIE") in which the Company is the primary beneficiary. Effective August 1, 2009, the Company adopted the accounting standards for non-controlling interests and reclassified the equity attributable to its non-controlling interests as a component of equity in the accompanying consolidated balance sheets. All significant intercompany balances and transactions have been eliminated in consolidation. See Note 3.


Management's determination of the appropriate accounting method with respect to the Company's variable interests is based on accounting standards for VIEs issued by the Financial Accounting Standards Board ("FASB"). The Company consolidates any VIEs in which it is the primary beneficiary and discloses significant variable interests in VIEs of which it is not the primary beneficiary, if any.


USE OF ESTIMATES


The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the year. Actual results could differ from those estimates. Significant estimates include amounts for impairment of equipment, share based compensation, inventory obsolescence and allowance for doubtful accounts.


FOREIGN CURRENCY TRANSLATION


After operations of the Company moved from Ontario, Canada to California, the Company reviewed its functional currency and determined that it was appropriate to change the functional currency to the U.S. dollar from the Canadian dollar May 1, 2012.


Prior to May 1, 2012, our financial information was translated into U.S. dollars using exchange rates in effect at period-end. The income statement is translated at the average year-to-date exchange rate. Adjustments resulting from translation of foreign exchange are included as a component of other comprehensive income within stockholders' deficit.


VALUATION OF LONG-LIVED ASSETS


We assess the recoverability of long-lived assets whenever events or changes in business circumstances indicate that the carrying value may not be recoverable. An impairment loss is recognized when the sum of the expected undiscounted net cash flows over the remaining useful life is less than the carrying amount of the assets.


 

F-6




REVENUE RECOGNITION


The Company recognizes revenue in accordance with FASB ASC Subtopic 605, Revenue Recognition.  Under FASB ASC Subtopic 605, revenue is recognized at the point of passage to the customer of title and risk of loss, there is persuasive evidence of an arrangement, the sales price is determinable, and collection of the resulting receivable is reasonably assured. The Company generally recognizes revenue at the time of delivery of goods. Sales are reflected net of sales taxes, discounts and returns.


CASH AND CASH EQUIVALENTS


Cash equivalents consist of highly liquid investments with maturities of three months or less when purchased.  Cash and cash equivalents are on deposit with financial institutions without any restrictions. At October 31, 2012 and July 31, 2012, cash equivalents amounted to $0.


ALLOWANCE FOR DOUBTFUL ACCOUNTS


The Company records an allowance for doubtful accounts as a best estimate of the amount of probable credit losses in its accounts receivable.  Each month, the Company reviews this allowance and considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured.  Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Receivables are charged off against the allowance for doubtful accounts when it becomes probable that a receivable will not be recovered. At October 31, 2012 and July 31, 2012, the allowance for doubtful accounts amounted to $0.


FAIR VALUE OF FINANCIAL INSTRUMENTS


The Company's financial instruments comprise cash, accounts receivable, accounts payable and accrued liabilities, notes payable to The Cellular Connection Ltd. and Larry Burke, and advances from related parties.  The carrying value of Company's short-term instruments approximates fair value, unless otherwise noted, due to the short-term maturity of these instruments.  In management's opinion, the fair value of notes payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest, currency or credit risks in respect of these financial instruments.


INVENTORY


Inventory comprises finished goods held for sale and is stated at lower of cost or market value.  Cost is determined by the average cost method.  The Company estimates the realizable value of inventory based on assumptions about forecasted demand, market conditions and obsolescence.  If the estimated realizable value is less than cost, the inventory value is reduced to its estimated realizable value.  If estimates regarding demand and market conditions are inaccurate or unexpected changes in technology affect demand, the Company could be exposed to losses in excess of amounts recorded.


STOCK-BASED COMPENSATION


The Company follows FASB ASC Subtopic 718, Stock Compensation, for accounting for stock-based compensation. The guidance requires that new, modified and unvested share-based payment transactions with employees, such as grants of stock options and restricted stock, be recognized in the consolidated financial statements based on their fair value at the grant date and recognized as compensation expense over their vesting periods.  The Company also follows the guidance for equity instruments issued to consultants.



 

F-7





LOSS PER SHARE


FASB ASC Subtopic 260, Earnings Per Share, provides for the calculation of "Basic" and "Diluted" earnings per share. Basic earnings per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period. All potentially dilutive securities have been excluded from the computations since they would be antidilutive. However, these dilutive securities could potentially dilute earnings per share in the future.


COMPREHENSIVE INCOME


The Company has adopted FASB ASC Subtopic 220, Comprehensive Income, which establishes standards for reporting and display of comprehensive income, its components and accumulated balances.  Comprehensive income is defined to include all changes in equity except those resulting from investments by owners or distributions to owners.  Among other disclosures, FASB ASC Subtopic 220 requires that all items that are required to be recognized under the current accounting standards as a component of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements.  Comprehensive income is displayed in the statement of operations and comprehensive loss and in the balance sheet as a component of stockholders' deficit.


RECENT ACCOUNTING PRONOUNCEMENTS


There have been no recent accounting pronouncements or changes in accounting pronouncements that impacted the first quarter of fiscal 2013, or which are expected to impact future periods, that were not already adopted and disclosed in prior periods.


NOTE 3 - VARIABLE INTEREST ENTITY


Following is a description of our financial interests in a variable interest entity that we consider significant, those for which we have determined that we are the primary beneficiary of the entity and, therefore, have consolidated the entity into our financial statements.


On April 26, 2012, we entered into a License Agreement with Vital Products Supplies, Inc. (“Vital Supplies”). Under the terms of the Agreement, we have the right to market the products of Vital Supplies as well as the right of use of the facilities of Vital Supplies including but not limited to the sales and distribution facilities. We agreed to pay a fee of 1.5% of all sales generated plus a management fee of 1.5% based on the total monies paid for employee salaries, benefits and commissions. The Company is responsible for all expenses that relate to sales generated under the License Agreement.  The duration of the agreement is for a period of twelve months commencing on April 26, 2012 and thereafter on a month-by-month basis unless sooner terminated by Vital Supplies as provided for in the agreement. Vital Supplies may at any time in its sole discretion, with sixty days prior notice, terminate the agreement and revoke the license granted for any reason whatsoever and upon such termination we will immediately stop the use of the facilities as described.


We have determined that we are the primary beneficiary of Vital Supplies as our interest in the entity is subject to variability based on results from operations and changes in the fair value.


The results of operations for Vital Supplies have been included in the financial statements of the Company. The Company did not pay consideration to enter into the License Agreement. The acquisition has been accounted for using the purchase method as follows:


Cash

$

200

Non-controlling interest

 

(200)

 

$

-



 

F-8




 

Vital Products Supplies, Inc. – At October 31, 2012 our consolidated balance sheet recognizes current assets of $232,251, and accounts payable and accrued liabilities of $242,682 related to our interests in Vital Supplies.  Our statement of operations recognizes sales of $554,458, cost of sales of $484,618 and selling, general and administrative expenses of $56,222 related to our interest in Vital Supplies for the period from August 1, 2012 to October 31, 2012.


 

NOTE 4 - NOTES PAYABLE TO THE CELLULAR CONNECTION LTD. AND LARRY BURKE


 

Original Date of Issuance

Maturity
Date

 

October 31, 2012

 

July 31, 2012

Promissory Note 7       

May 27, 2010       

May 26, 2013

$

53,280

$

53,280

Promissory Note 9

November 29, 2010  

November 28, 2013

 

58,800

 

58,800

Promissory Note 12

April 7, 2011

April 6, 2013

 

38,400

 

38,400

Promissory Note 13      

February 24, 2012  

February 23, 2013  

 

27,241     

 

27,241

Interest

 

 

 

36,412

 

23,773

Accretion

 

 

 

63,270

 

42,909

 

 

 

$

277,403

$

244,403


As of October 31, 2012 and July 31, 2012 notes payable are recorded net of unamortized debt discount of $45,088 and $78,088, respectively.


Each of the notes bears interest at 20% per annum and allow for the lender to secure a portion of the Company assets up to 200% of the face value of the note and mature one year from the day of their respective issuance. Unless otherwise indicated, the holder has the right to convert the Notes plus accrued interest into shares of the Company's common stock at any time prior to the maturity date. The number of common stock to be issued will be determined using a conversion price based on 75% of the average of the lowest closing bid price during the fifteen trading days immediately prior to conversion.


NOTE 5 - ADVANCES


Advances from a non-related party for business expenses are non-interest bearing, unsecured and have no-specific terms of repayment.


NOTE 6 - RELATED PARTY BALANCES AND TRANSACTIONS

 

During the three months ended October 31, 2012 and 2011, the Company had sales of $554,458 and $0, respectively, and as of October 31, 2012 and July 31, 2012 accounts receivable of $103,554 and $128,320, respectively, all with Century Computer Products, Inc. ("Century") and Reliable Printing Solutions, Inc. ("Reliable"). Aaron Shrira, the sole shareholder of Vital Supplies, is a 50% shareholder of both Century and Reliable. Vital Supplies is a consolidated subsidiary of Vital Products. We have determined that we are the primary beneficiary of Vital Supplies as our interest in the entity is subject to variability based on results from operations and changes in the fair value.


At October 31, 2012 and July 31, 2012, the Company has advances of $9,000 and $0, respectively, due to Century. The advances are non-interest bearing, unsecured and have no specific terms of repayment.


For the three months ended October 31, 2012 and 2011, the Company had rent expense totaling $0 and $9,030, respectively and as of October 31, 2012 and July 31, 2012 advances due of $31,257 and $31,891, respectively, and outstanding payables totaling $191,124 and $195,001, respectively, all with Zynpak Packaging Inc. in which the Company's former Chief Executive Officer has a majority ownership interest. The balances are non-interest bearing, unsecured and have no specified terms of repayment.



F-9




 

As of October 31, 2012 and July 31, 2012, the Company has advances of $101,971 and $104,039, respectively, due to Den Packaging Corporation in which the Company's former Chief Executive Officer has a majority ownership interest. The balances are non-interest bearing, unsecured and have no specified terms of repayment.


NOTE 7 – CONVERTIBLE PREFERRED AND CAPITAL STOCK


Each Series A Preferred Stock is convertible at any time, at the option of the holder, into 100 shares of common stock. Series A Preferred Stocks carry voting rights equal to the number of common shares into which the preferred stock can be converted, multiplied by 30. Upon any liquidation, dissolution or winding-up of the Company, the Holders shall be entitled to receive out of the assets of the Company, whether such assets are capital or surplus, for each share of Preferred Stock an amount equal to the holder's pro rata share of the assets and funds of the Company.


NOTE 8 - RISK MANAGEMENT


Foreign Exchange Risk


At October 31, 2012 and July 31, 2012, the Company had trade payables and advances of $357,739 and $364,997, respectively, due in Canadian dollars. The Company does not use derivative instruments to hedge its foreign exchange risk.


Concentration Risk


The Company is subject to risk of non-payment on its trade accounts receivable. For the three months ended October 31, 2012, the company has few customers. Two related party customers, Reliable Printing and Century Computer represent 100% of the total outstanding accounts receivable and those same two related party customers represent 100% of total sales. Management consistently monitors its client credit terms with customers to reduce credit risk exposure.


For the three months ended October 31, 2012, the company purchased its inventory from many vendors.



F-10

 



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS


This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties.  You should not place undue reliance on these forward-looking statements.  Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed November 2, 2012, for the year ended July 31, 2012, and other filings we make with the Securities and Exchange Commission.  Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.


The following discussion and analysis of financial condition and results of operations is based upon, and should be read in conjunction with our audited financial statements and related notes thereto included elsewhere in this report, and in our Form 10-K filed November 2, 2012, for the year ended July 31, 2012.


OVERVIEW


Vital Products, Inc. (the "Company") was incorporated in the State of Delaware on May 27, 2005. On July 5, 2005, the Company purchased the Childcare Division of Metro One Development, Inc., (formerly On The Go Healthcare, Inc.) which manufactured and distributed infant care products.There is no material assets or revenues that relate to the discontinued Childcare Division.



On April 26, 2012, we entered into a License Agreement with Vital Products Supplies, Inc. (“Vital Supplies”). Under the terms of the Agreement, we have the right to market the products of Vital Supplies as well as the right of use of the facilities of Vital Supplies including but not limited to the sales and distribution facilities. We agreed to pay a fee of 1.5% of all sales generated plus a management fee of 1.5% based on the total monies paid for employee salaries, benefits and commissions. The Company is responsible for all expenses that relate to sales generated under the License Agreement.  The duration of the agreement is for a period of twelve months commencing on April 26, 2012 and thereafter on a month-by-month basis unless sooner terminated by Vital Supplies as provided for in the agreement. Vital Supplies may at any time in its sole discretion, with sixty days prior notice, terminate the agreement and revoke the license granted for any reason whatsoever and upon such termination we will immediately stop the use of the facilities as described.


The Company has determined that Vital Supplies is a Variable Interest Entity and that Vital Products, Inc. is the primary beneficiary. As such, Den Packaging Corporation has been consolidated into the Company’s financial statements.


The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to us and on various other assumptions that management believes to be reasonable under the circumstances. Actual results could vary from those estimates and we may change our estimates and assumptions in future evaluations. Changes in these estimates and assumptions may have a material effect on our financial condition and results of operations. We believe that these critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements. For a discussion of our significant accounting policies and estimates, please refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” presented in our 2012 Annual Report on Form 10-K filed on November 2, 2012.




3





There were no newly identified significant accounting estimates during the three months ended October 31, 2012, nor were there any material changes to the critical accounting policies and estimates discussed in our 2012 Annual Report on Form 10-K.


EFFECT OF NEW ACCOUNTING PRONOUNCEMENTS


There have been no recent accounting pronouncements or changes in accounting pronouncements that impacted the first quarter of fiscal 2013, or which are expected to impact future periods, that were not already adopted and disclosed in prior periods.


RESULTS OF OPERATIONS


COMPARISON OF RESULTS FOR THE THREE MONTHS ENDED OCTOBER 31, 2012 AND 2011


REVENUES:


We had revenues of $554,458 and $4,634 for the three months ended October 31, 2012 and 2011. The increase in revenues was primarily the result of the License Agreement with Vital Supplies on April 26, 2012. As a result of the License Agreement, the Company has determined that it is the primary beneficiary Vital Supplies, a Variable Interest Entity, and Vital Supplies has been fully consolidated in our financial statements.


COST OF SALES:


Our cost of sales for the three months ended October 31, 2012 and 2011 was $484,618 and $2,754, respectively. The increase in cost of sales as compared to the previous quarter was primarily the result of the License Agreement with Vital Supplies on April 26, 2012.


SELLING, GENERAL AND ADMINISTRATIVE EXPENSES:


Our selling, general and administrative and consulting costs were $72,981 and $22,130 for the three months ended October 31, 2012 and 2011, respectively. The increase in selling, general and administrative expenses as compared to the previous quarter was primarily the result of the License Agreement with Vital Supplies on April 26, 2012.


NET LOSS:


Our net loss attributed to Vital Products Inc. for the three months ended October 31, 2012 and 2011 was $28,883 and $63,086, respectively.  The decrease of the net loss compared to the prior period was primarily to the increase in sales comparable to the prior period. Finance costs were $33,000 and $35,456 for the three months ended October 31, 2012 and 2011, respectively, relates to interest accretion expense on convertible notes payable.


TOTAL ASSETS:


Our total assets as of October 31, 2012 were $251,686, an increase of $3,103, as compared to the fiscal year ended July 31, 2012 which was $244,583. Our total liabilities as of October 31, 2012 were $1,019,954, an increase of $31,986, as compared to $987,968 as of July 31, 2011. The increase in our total liabilities compared to July 31, 2011 was primarily the result of the increased advances from loans, related parties and vendors.


LIQUIDITY AND CAPITAL RESOURCES


As of October 31, 2012, we had total current assets of $247,686 and total current liabilities of $1,019,954, resulting in a working capital deficit of $772,269.  At the end of the quarterly period ending October 31, 2012, we had cash of $20,072.  Our cash flow provided by operating activities for the three months ended October 31, 2012 is $2,829. Our current cash balance and cash flow from operating activities will not be sufficient to fund our operations. Our cash flow from financing activities for the three months ended October 31, 2012 was $20,193. We believe we will need to raise capital of approximately $300,000 to $350,000 through either debt or equity instruments to fund our operations for the next 12 months. However, we may not be successful in raising the necessary capital to fund our operations. In addition to the amounts needed to fund our operations, we will need to generate an additional $500,000 to cover our current liabilities for the next 12 months.



4




 

 


As of October 31, 2012, we have $277,403 of convertible notes payable due to The Cellular Connection Ltd. and Larry Burke. The aggregate amount due under four convertible secured promissory notes with an aggregate face amount of $322,491. Convertible notes payable are recorded on our balance sheet net of debt discount of $45,088. We issued these notes to The Cellular Connection Ltd. and Larry Burke during 2012, 2011, 2010 and 2009. The carrying value of convertible notes payable of $277,403 includes accreted interest totaling $99,682 and actual loan amount totaling $177,721.


The convertible secured promissory notes accrue interest at a rate of 20% per year and have maturity dates as disclosed in Note 4 of the consolidated financial statements for the period ended October 31, 2012. The outstanding face amount of the convertible secured promissory notes increase by 20% in 2011, an additional 20% in 2012 and again on each one year anniversary after 2012 until the notes have been paid in full. The notes entitle the holder to convert the note, plus accrued interest, any time prior to the maturity date, at 75% of the average of the lowest closing bid price during the fifteen trading days immediately preceding the conversion date.


Pursuant to the terms of the convertible secured promissory notes, The Cellular Connection Ltd. may elect to secure a portion of our assets not to exceed 200% of the face amount of the notes, including, but not limited to, accounts receivable, cash, marketable securities, equipment, or inventory.


Until we are able to generate positive cash flows from operations in an amount sufficient to cover our current liabilities and debt obligations as they become due, if ever, we will remain reliant on borrowing funds or selling equity. We intend to raise funds through the issuance of debt or equity. Raising funds in this manner typically requires much time and effort to find accredited investors, and the terms of such an investment must be negotiated for each investment made. There is a risk that such additional financing may not be available, or may not be available on acceptable terms, and the inability to obtain additional financing or generate sufficient cash from operations could require us to reduce or eliminate expenditures for capital equipment, production, design or marketing of our products, or otherwise curtail or discontinue our operations, which could have a material adverse effect on our business, financial condition and results of operations. We may not be able to raise sufficient funds to meet our obligations. If we do not raise sufficient funds, our operations will be curtailed or will cease entirely and you may lose all of your investment.


Further, to the extent that we raise capital through the sale of equity or convertible debt securities, the issuance of such securities may result in dilution to our existing stockholders.  If we raise additional funds through issuance of debt securities, these securities may have rights, preferences and privileges senior to holders of our common stock and the terms of such debt could impose restrictions on our operations.  Regardless of whether our cash assets prove to be adequate to meet our operational needs, we may seek to compensate our service providers with stock in lieu of cash, which may also result in dilution to existing stockholders.


OFF-BALANCE SHEET ARRANGEMENTS


As of October 31, 2012, we have no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.






5






ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item. 9.



ITEM 4T. CONTROLS AND PROCEDURES


DISCLOSURE CONTROLS AND PROCEDURES


Our management evaluated, with the participation of our Principal Executive Officer and our Principal Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this quarterly report on Form 10-Q.  Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are not effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Principal Executive Officer and our Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.  Our disclosure controls and procedures are designed to provide reasonable assurance that such information is accumulated and communicated to our management.  Our disclosure controls and procedures include components of our internal control over financial reporting.  Management's assessment of the effectiveness of our internal control over financial reporting is expressed at the level of reasonable assurance that the control system, no matter how well designed and operated, can provide only reasonable, but not absolute, assurance that the control system's objectives will be met.




CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING


There were no changes in our internal control over financial reporting that occurred during the quarter ended October 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


PART II - OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS


We may be involved from time to time in ordinary litigation, negotiation and settlement matters that will not have a material effect on our operations or finances. We are not aware of any pending or threatened litigation against our Company or our officers and directors in their capacity as such that could have a material impact on our operations or finances.


ITEM 1A. RISK FACTORS


There have been no material changes in our risk factors from those disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended July 31, 2012.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS


During the quarter ended October 31, 2012, we did not sell any unregistered securities.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES


During the quarter ended October 31, 2012, we did not have any defaults upon senior securities.



6






ITEM 4. MINE SAFETY DISCLOSURES


Not applicable.


ITEM 5. OTHER INFORMATION


Not applicable.














7






ITEM 6. EXHIBITS


Exhibit No.

  

Description of Exhibit

3.1

 

Certificate of Incorporation (included as exhibit 3.1 to the Form SB-2 filed August 29, 2005 and incorporated herein by reference).

3.2

 

By-laws (included as exhibit 3.2 to the Form SB-2 filed August 29, 2005 and incorporated herein by reference).

4.1

 

Form of Stock Certificate (included as exhibit 4.1 to the Form SB-2 filed October 26, 2006 and incorporated herein by reference).

4.2

 

Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, dated April 20, 2009 (included as exhibit 4.1 to the Form 8-K filed April 24, 2009 and incorporated herein by reference).

10.1

 

Asset Sale Agreement between the Company and On The Go Healthcare, Inc. dated July 5, 2005 (included as exhibit 10.3 to the Form SB-2 filed August 29, 2005 and incorporated herein by reference).

10.2

 

Secured Promissory Note between the Company and On The Go Healthcare, Inc. dated February 23, 2006 (included as exhibit 10.2 to the Form SB-2 filed February 24, 2006 and incorporated herein by reference).

10.3

 

Secured Promissory Note between the Company and On The Go Healthcare, Inc. dated February 23, 2006 (included as exhibit 10.3 to the Form SB-2 filed February 24, 2006 and incorporated herein by reference).

10.4

 

Secured Promissory Note between the Company and The Cellular Connection Ltd. dated January 20, 2009 (included as exhibit 10.5 to the Form 10-Q filed March 20, 2009 and incorporated herein by reference).

10.5

 

Convertible Promissory Note between the Company and Metro One Development, Inc. dated June 18, 2009 (included as exhibit 10.5 to the Form 10-Q   filed June 19, 2009 and incorporated herein by reference).

10.6

 

Secured Promissory Note between the Company and The Cellular Connection Ltd. dated April 30, 2009 (included as exhibit 10.6 to the Form 10-Q filed June 19, 2009 and incorporated herein by reference).

31.1

 

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).

32.1  

 

Certification of Officers pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).



8






SIGNATURES


 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



 

VITAL PRODUCTS, INC.

 

 

 

 

Dated: December 17, 2012

 

 

By:

/s/ James McKinney

 

 

Name:

James McKinney

 

 

Title:

Principal Executive Officer, Principal Financial Officer and Director






 

 

 

 

 

 

 



9